Details of Drug

Drug General Information (ID: D1193)
Drug Name	Oxaliplatin
Drug Type	Small molecule
Drug Synonymous	Eloxatin (TN); Medac (TN); Oxaliplatin (TN); Oxaliplatin (JAN/USAN/INN) Click to Show/Hide
Disease Class	2B91: Colorectal cancer
Therapeutic Class	Antineoplastics
Structure
Structure	3D Structure		2D Structure
Formula	C8H14N2O4Pt
InChI	1S/C6H12N2.C2H2O4.Pt/c7-5-3-1-2-4-6(5)8;3-1(4)2(5)6;/h5-8H,1-4H2;(H,3,4)(H,5,6);/q-2;;+2/t5-,6-;;/m1../s1
InChIKey	DRMCATBEKSVAPL-BNTLRKBRSA-N
Canonical SMILES	C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2]
External Link
	Pubchem ID	9887053
	CAS Number	61825-94-3
	TTD ID	D0Y3ME
	INTEDE ID	DR1210
	VARIDT ID	DR00316

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM005 Affected excretion pathways AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM027 Decreased renal excretion due to nephrotoxicity BM038 Additive CNS depression effects BM042 Additive hypotensive effects BM043 Additive immunosuppressive effects BM044 Additive myelosuppressive effects BM047 Additive thrombogenic effects BM049 Increased risk of atrioventricular block BM055 Increased risk of hepatotoxicity BM072 Increased risk of nephrotoxicity BM074 Increased risk of peripheral neuropathy BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias BM100 Antagonize the effect of vaccine/toxoid BM105 Antagonize the effect of probiotics BM106 Diminish the response to diagnostic skin test antigens BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Oxaliplatin
Affected excretion pathways
	Decreased renal excretion due to nephrotoxicity					Drug Num: 66
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0056		Amikacin	C22H43N5O13	37768	Moderate		Inter Info	[203]
D0057		Amikacin (liposome)	C22H43N5O13	37768	Moderate		Inter Info	[203]
D0252		Capreomycin	C50H88N28O15	3000502	Moderate		Inter Info	[203]
D0298		Celecoxib	C17H14F3N3O2S	2662	Moderate		Inter Info	[203]
D0335		Cidofovir	C8H14N3O6P	60613	Moderate		Inter Info	[203]
D0402		Cyclosporine	C62H111N11O12	5284373	Moderate		Inter Info	[203]
D0800		Indomethacin	C19H16ClNO4	3715	Moderate		Inter Info	[203]
D0882		Ketorolac	C15H13NO3	3826	Moderate		Inter Info	[203]
D1009		Mesalazine	C7H7NO3	4075	Moderate		Inter Info	[203]
D1097		Nabumetone	C15H16O2	4409	Moderate		Inter Info	[203]
D0076		Amphotericin B (cholesteryl sulfate)	C47H73NO17	5280965	Moderate		Inter Info	[203]
D0077		Amphotericin B (lipid complex)	C47H73NO17	5280965	Moderate		Inter Info	[203]
D0078		Amphotericin B (liposomal)	C47H73NO17	5280965	Moderate		Inter Info	[203]
D0142		Bacitracin	C66H103N17O16S	10909430	Moderate		Inter Info	[203]
D0145		Balsalazide	C17H15N3O6	54585	Moderate		Inter Info	[203]
D0210		Bromfenac	C15H12BrNO3	60726	Moderate		Inter Info	[203]
D0383		Colistimethate	C58H105N16O28S5-5	70789202	Moderate		Inter Info	[203]
D0432		Deferasirox	C21H15N3O4	214348	Moderate		Inter Info	[203]
D0476		Diclofenac	C14H11Cl2NO2	3033	Moderate		Inter Info	[203]
D0489		Diflunisal	C13H8F2O3	3059	Moderate		Inter Info	[203]
D0623		Etidronic acid	C2H8O7P2	3305	Moderate		Inter Info	[203]
D0624		Etodolac	C17H21NO3	3308	Moderate		Inter Info	[203]
D0645		Fenoprofen	C15H14O3	3342	Moderate		Inter Info	[203]
D0668		Flucytosine	C4H4FN3O	3366	Moderate		Inter Info	[307]
D0680		Flurbiprofen	C15H13FO2	3394	Moderate		Inter Info	[203]
D0694		Foscarnet	CH3O5P	3415	Moderate		Inter Info	[203]
D0709		Gallium nitrate	GaN3O9	61635	Moderate		Inter Info	[203]
D0718		Gentamicin	C21H43N5O7	3467	Moderate		Inter Info	[203]
D0724		Givosiran	C78H139N11O30	119058042	Moderate		Inter Info	[203]
D0783		Ibandronate	C9H23NO7P2	60852	Moderate		Inter Info	[203]
D0786		Ibuprofen	C13H18O2	3672	Moderate		Inter Info	[203]
D0805		Inotersen	C230H318N69O121P19S19	121492004	Moderate		Inter Info	[203]
D0829		Iobenguane (I-131)	C8H10IN3	60860	Moderate		Inter Info	[203]
D0876		Kanamycin	C18H36N4O11	6032	Moderate		Inter Info	[203]
D0881		Ketoprofen	C16H14O3	3825	Moderate		Inter Info	[203]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[203]
D0964		Lutetium Lu 177 dotatate	C65H87LuN14O19S2	76966897	Moderate		Inter Info	[203]
D0988		Meclofenamic acid	C14H11Cl2NO2	4037	Moderate		Inter Info	[203]
D0991		Mefenamic acid	C15H15NO2	4044	Moderate		Inter Info	[203]
D0995		Meloxicam	C14H13N3O4S2	54677470	Moderate		Inter Info	[203]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[203]
D1030		Methoxyflurane	C3H4Cl2F2O	4116	Moderate		Inter Info	[203]
D1091		Moxetumomab Pasudotox	NA	NA	Moderate		Inter Info	[203]
D1109		Naproxen	C14H14O3	156391	Moderate		Inter Info	[203]
D1120		Neomycin	C23H46N6O13	8378	Moderate		Inter Info	[203]
D1126		Netilmicin	C21H41N5O7	441306	Moderate		Inter Info	[203]
D1173		Olsalazine	C14H10N2O6	22419	Moderate		Inter Info	[203]
D1196		Oxaprozin	C18H15NO3	4614	Moderate		Inter Info	[203]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[203]
D1274		Phenylbutazone	C19H20N2O2	4781	Moderate		Inter Info	[203]
D1300		Piroxicam	C15H13N3O4S	54676228	Moderate		Inter Info	[203]
D1310		Polymyxin B	C56H98N16O13	49800004	Moderate		Inter Info	[203]
D1421		Rofecoxib	C17H14O4S	5090	Moderate		Inter Info	[203]
D1442		Salsalate	C14H10O5	5161	Moderate		Inter Info	[203]
D1476		Sirolimus	C51H79NO13	5284616	Moderate		Inter Info	[203]
D1507		Streptomycin	C21H39N7O12	19649	Moderate		Inter Info	[203]
D1517		Sulfasalazine	C18H14N4O5S	5339	Moderate		Inter Info	[203]
D1520		Sulindac	C20H17FO3S	1548887	Moderate		Inter Info	[203]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[203]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[203]
D1549		Temsirolimus	C56H87NO16	6918289	Moderate		Inter Info	[203]
D1597		Tobramycin	C18H37N5O9	36294	Moderate		Inter Info	[203]
D1674		Valdecoxib	C16H14N2O3S	119607	Moderate		Inter Info	[203]
D1217		Pamidronic acid	C3H11NO7P2	4674	Moderate		Inter Info	[203]
D1606		Tolmetin	C15H15NO3	5509	Moderate		Inter Info	[203]
D1727		Zoledronic acid	C5H10N2O7P2	68740	Moderate		Inter Info	[203]
Pharmacodynamic additive effects
	Additive CNS depression effects					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0452		Deutetrabenazine	C19H27NO3	73437646	Moderate		Inter Info	[299]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[378]
	Additive hypotensive effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[7], [8], [9], [323], [13]
	Additive immunosuppressive effects					Drug Num: 70
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0023		Adalimumab	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0348		Cladribine	C10H12ClN5O3	20279	Major		Inter Info	[9], [15]
D0614		Etanercept	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D0802		Infliximab	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D1111		Natalizumab	NA	NA	Major		Inter Info	[73]
D0146		Baricitinib	C16H17N7O2S	44205240	Major		Inter Info	[8], [9], [78]
D0304		Certolizumab pegol	NA	NA	Major		Inter Info	[1], [5], [6]
D0736		Golimumab	NA	NA	Major		Inter Info	[1], [2], [3], [4], [5], [6]
D1600		Tofacitinib	C16H20N6O	9926791	Major		Inter Info	[182]
D1666		Upadacitinib	C17H19F3N6O	58557659	Major		Inter Info	[187]
D0030		Aldesleukin	NA	NA	Moderate		Inter Info	[9], [125], [198]
D0032		Alefacept	NA	NA	Moderate		Inter Info	[153], [199], [200]
D0033		Alemtuzumab	NA	NA	Moderate		Inter Info	[201]
D0085		Anakinra	C20H23N5O7S2	146171046	Moderate		Inter Info	[204], [205], [206]
D0190		Bleomycin	C55H84N17O21S3+	5360373	Moderate		Inter Info	[9], [125], [198]
D0264		Carmustine	C5H9Cl2N3O2	2578	Moderate		Inter Info	[9], [125], [198]
D0306		Cetuximab	NA	NA	Moderate		Inter Info	[8], [9]
D0312		Chlorambucil	C14H19Cl2NO2	2708	Moderate		Inter Info	[9], [125], [198]
D0553		Efalizumab	NA	NA	Moderate		Inter Info	[223]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[9], [125], [198]
D0666		Floxuridine	C9H11FN2O5	5790	Moderate		Inter Info	[9], [125], [198]
D0714		Gemcitabine	C9H11F2N3O4	60750	Moderate		Inter Info	[9], [125], [198]
D1077		Mitomycin	C15H18N4O5	5746	Moderate		Inter Info	[9], [125], [198]
D0136		Azathioprine	C9H7N7O2S	2265	Moderate		Inter Info	[8], [9]
D0157		Bendamustine	C16H21Cl2N3O2	65628	Moderate		Inter Info	[9], [125], [198]
D0223		Busulfan	C6H14O6S2	2478	Moderate		Inter Info	[9], [125], [198]
D0246		Canakinumab	NA	NA	Moderate		Inter Info	[204], [205], [206]
D0249		Capecitabine	C15H22FN3O6	60953	Moderate		Inter Info	[9], [125], [198]
D0400		Cyclophosphamide	C7H15Cl2N2O2P	2907	Moderate		Inter Info	[9], [125], [198]
D0404		Cytarabine	C9H13N3O5	6253	Moderate		Inter Info	[9], [125], [198]
D0407		Dacarbazine	C6H10N6O	135398738	Moderate		Inter Info	[9], [125], [198]
D0410		Dactinomycin	C62H86N12O16	457193	Moderate		Inter Info	[9], [125], [198]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[9], [125], [198]
D0431		Decitabine	C8H12N4O4	451668	Moderate		Inter Info	[9], [125], [198]
D0443		Denosumab	NA	NA	Moderate		Inter Info	[298]
D0499		Dimethyl fumarate	C6H8O4	637568	Moderate		Inter Info	[300]
D0507		Diroximel fumarate	C11H13NO6	73330464	Moderate		Inter Info	[300]
D0528		Doxorubicin	C27H29NO11	31703	Moderate		Inter Info	[9], [125], [198]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Moderate		Inter Info	[9], [125], [198]
D0675		Fluorouracil	C4H3FN2O2	3385	Moderate		Inter Info	[9], [125], [198]
D0780		Hydroxyurea	CH4N2O2	3657	Moderate		Inter Info	[9], [125], [198]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[9], [125], [198]
D0790		Ifosfamide	C7H15Cl2N2O2P	3690	Moderate		Inter Info	[9], [125], [198]
D0793		Imatinib	C29H31N7O	5291	Moderate		Inter Info	[9], [125], [198]
D0851		Isatuximab	NA	NA	Moderate		Inter Info	[9], [125], [198]
D0945		Lomustine	C9H16ClN3O2	3950	Moderate		Inter Info	[9], [125], [198]
D0962		Lurbinectedin	C41H44N4O10S	57327016	Moderate		Inter Info	[9], [125], [198]
D0986		Mechlorethamine	C5H11Cl2N	4033	Moderate		Inter Info	[9], [125], [198]
D0996		Melphalan	C13H18Cl2N2O2	460612	Moderate		Inter Info	[9], [125], [198]
D1007		Mercaptopurine	C5H4N4S	667490	Moderate		Inter Info	[9], [125], [198]
D1079		Mitoxantrone	C22H28N4O6	4212	Moderate		Inter Info	[9], [125], [198]
D1085		Monomethyl fumarate	C5H6O4	5369209	Moderate		Inter Info	[300]
D1140		Niraparib	C19H20N4O	24958200	Moderate		Inter Info	[326]
D1162		Ocrelizumab	NA	NA	Moderate		Inter Info	[327]
D1167		Olaparib	C24H23FN4O3	23725625	Moderate		Inter Info	[9], [328]
D1174		Omacetaxine mepesuccinate	C29H39NO9	285033	Moderate		Inter Info	[329]
D1241		Pemetrexed	C20H21N5O6	135410875	Moderate		Inter Info	[9], [125], [198]
D1250		Pentostatin	C11H16N4O4	439693	Moderate		Inter Info	[9], [125], [198]
D1375		Radium Ra 223 dichloride	NA	NA	Moderate		Inter Info	[357]
D1403		Rilonacept	NA	NA	Moderate		Inter Info	[204], [205], [206]
D1422		Roflumilast	C17H14Cl2F2N2O3	449193	Moderate		Inter Info	[9], [361]
D1434		Ruxolitinib	C17H18N6	25126798	Moderate		Inter Info	[9], [125], [198]
D1487		Sodium phosphate, monobasic (p32)	NA	NA	Moderate		Inter Info	[363]
D1509		Strontium chloride Sr-89	Cl2Sr	5388879	Moderate		Inter Info	[8], [9], [364]
D1548		Temozolomide	C6H6N6O2	5394	Moderate		Inter Info	[9], [125], [198]
D1575		Thiotepa	C6H12N3PS	5453	Moderate		Inter Info	[9], [125], [198]
D1671		Ustekinumab	NA	NA	Moderate		Inter Info	[376]
D1855		Palifermin	NA	NA	Moderate		Inter Info	[380]
D1508		Streptozocin	C8H15N3O7	29327	Moderate		Inter Info	[9], [125], [198]
D1720		Zidovudine	C10H13N5O4	35370	Moderate		Inter Info	[8], [9], [388]
	Additive myelosuppressive effects					Drug Num: 6
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0370		Clozapine	C18H19ClN4	135398737	Major		Inter Info	[16], [17]
D0433		Deferiprone	C7H9NO2	2972	Major		Inter Info	[8], [102], [103]
D1443		Samarium (153Sm) lexidronam	Sm	23951	Major		Inter Info	[146]
D1610		Topotecan	C23H23N3O5	60700	Major		Inter Info	[183], [184], [185]
D0710		Ganciclovir	C9H13N5O4	135398740	Moderate		Inter Info	[8], [9], [309], [310]
D1676		Valganciclovir	C14H22N6O5	135413535	Moderate		Inter Info	[8], [9], [309], [310]
	Additive thrombogenic effects					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1569		Thalidomide	C13H10N2O4	5426	Major		Inter Info	[162], [163], [164], [165], [166], [167], [168], [169], [170], [171], [172], [173], [174], [175], [176], [177]
	Increased risk of atrioventricular block					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[9], [115], [262]
	Increased risk of hepatotoxicity					Drug Num: 20
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[122]
D0944		Lomitapide	C39H37F6N3O2	9853053	Major		Inter Info	[124]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[129]
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[142]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[122]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[207], [208], [209], [8], [9], [210], [211], [212], [213], [214], [215], [216], [217]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[227], [228], [229], [230]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[227], [228], [229], [230]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[207], [208], [209], [8], [9], [210], [211], [212], [213], [214], [215], [216], [217]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[289], [290]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[207], [208], [209], [8], [9], [210], [211], [212], [213], [214], [215], [216], [217]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[9], [294]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[295]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[314]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[325]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[227], [228], [229], [230]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[8], [9], [358], [359], [360]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[9], [370]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[207], [208], [209], [8], [9], [210], [211], [212], [213], [214], [215], [216], [217]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[386], [387]
	Increased risk of nephrotoxicity					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1672		Valaciclovir	C13H20N6O4	135398742	Moderate		Inter Info	[9], [377]
	Increased risk of peripheral neuropathy					Drug Num: 64
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0193		Bortezomib	C19H25BN4O4	387447	Moderate		Inter Info	[218], [219], [220]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[221], [125], [222]
D0313		Chloramphenicol	C11H12Cl2N2O5	5959	Moderate		Inter Info	[221], [125], [222]
D0344		Cisplatin	Cl2H6N2Pt	5702198	Moderate		Inter Info	[221], [125], [222]
D0419		Dapsone	C12H12N2O2S	2955	Moderate		Inter Info	[221], [125], [222]
D0616		Ethambutol	C10H24N2O2	14052	Moderate		Inter Info	[221], [125], [222]
D0821		Interferon alfa-2a, Recombinant	NA	NA	Moderate		Inter Info	[221], [125], [222]
D0822		Interferon alfa-2b	C16H17Cl3I2N3NaO5S	71306834	Moderate		Inter Info	[221], [125], [222]
D0824		Interferon alfa-n1	NA	NA	Moderate		Inter Info	[221], [125], [222]
D0823		Interferon alfacon-1	NA	NA	Moderate		Inter Info	[221], [125], [222]
D0956		Lovastatin	C24H36O5	53232	Moderate		Inter Info	[221], [125], [222]
D0120		Atorvastatin	C33H35FN2O5	60823	Moderate		Inter Info	[221], [125], [222]
D0126		Auranofin	C20H34AuO9PS	24199313	Moderate		Inter Info	[221], [125], [222]
D0162		Benznidazole	C12H12N4O3	31593	Moderate		Inter Info	[221], [125], [222]
D0227		Cabazitaxel	C45H57NO14	9854073	Moderate		Inter Info	[221], [125], [222]
D0260		Carboplatin	C6H12N2O4Pt	426756	Moderate		Inter Info	[221], [125], [222]
D0261		Carfilzomib	C40H57N5O7	11556711	Moderate		Inter Info	[221], [125], [222]
D0380		Colchicine	C22H25NO6	6167	Moderate		Inter Info	[221], [125], [222]
D0483		Didanosine	C10H12N4O3	135398739	Moderate		Inter Info	[221], [125], [222]
D0496		Diiodohydroxyquinoline	C9H5I2NO	3728	Moderate		Inter Info	[221], [125], [222]
D0501		Dinutuximab	NA	NA	Moderate		Inter Info	[221], [125], [222]
D0509		Disulfiram	C10H20N2S4	3117	Moderate		Inter Info	[221], [125], [222]
D0511		Docetaxel	C43H53NO14	148124	Moderate		Inter Info	[221], [125], [222]
D0560		Elotuzumab	NA	NA	Moderate		Inter Info	[221], [125], [222]
D0571		Enfortumab vedotin	NA	NA	Moderate		Inter Info	[221], [125], [222]
D1731		Ethionamide	C8H10N2S	2761171	Moderate		Inter Info	[221], [125], [222]
D0627		Etoposide	C29H32O13	36462	Moderate		Inter Info	[221], [125], [222]
D0628		Etravirine	C20H15BrN6O	193962	Moderate		Inter Info	[221], [125], [222]
D0669		Fludarabine	C10H12FN5O4	657237	Moderate		Inter Info	[221], [125], [222]
D0686		Fluvastatin	C24H26FNO4	446155	Moderate		Inter Info	[221], [125], [222]
D0770		Hydralazine	C8H8N4	3637	Moderate		Inter Info	[221], [125], [222]
D0841		Ipilimumab	NA	NA	Moderate		Inter Info	[221], [125], [222]
D0858		Isoniazid	C6H7N3O	3767	Moderate		Inter Info	[221], [125], [222]
D0873		Ixabepilone	C27H42N2O5S	6445540	Moderate		Inter Info	[221], [125], [222]
D0874		Ixazomib	C14H19BCl2N2O4	25183872	Moderate		Inter Info	[221], [125], [222]
D0918		Levodopa	C9H11NO4	6047	Moderate		Inter Info	[221], [125], [222]
D0933		Linezolid	C16H20FN3O4	441401	Moderate		Inter Info	[221], [125], [222]
D1113		Naxitamab	NA	NA	Moderate		Inter Info	[221], [125], [222]
D1118		Nelarabine	C11H15N5O5	3011155	Moderate		Inter Info	[221], [125], [222]
D1145		Nitrofurantoin	C8H6N4O5	6604200	Moderate		Inter Info	[221], [125], [222]
D1212		Paclitaxel	C47H51NO14	36314	Moderate		Inter Info	[221], [125], [222]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[221], [125], [222]
D1301		Pitavastatin	C25H24FNO4	5282452	Moderate		Inter Info	[221], [125], [222]
D1306		Polatuzumab vedotin	NA	NA	Moderate		Inter Info	[221], [125], [222]
D1312		Pomalidomide	C13H11N3O4	134780	Moderate		Inter Info	[221], [125], [222]
D1430		Rosuvastatin	C22H28FN3O6S	446157	Moderate		Inter Info	[221], [125], [222]
D1452		Secnidazole	C7H11N3O3	71815	Moderate		Inter Info	[221], [125], [222]
D1473		Simvastatin	C25H38O5	54454	Moderate		Inter Info	[221], [125], [222]
D1479		Sodium aurothiomalate	C4H3AuNa2O4S	22318	Moderate		Inter Info	[221], [125], [222]
D1504		Stavudine	C10H12N2O4	18283	Moderate		Inter Info	[221], [125], [222]
D1543		Telbivudine	C10H14N2O5	159269	Moderate		Inter Info	[221], [125], [222]
D1587		Tinidazole	C8H13N3O4S	5479	Moderate		Inter Info	[221], [125], [222]
D1599		Tocilizumab	NA	NA	Moderate		Inter Info	[221], [125], [222]
D1623		Trastuzumab emtansine	NA	NA	Moderate		Inter Info	[221], [125], [222]
D1697		Vinblastine	C46H58N4O9	13342	Moderate		Inter Info	[221], [125], [222]
D1698		Vincristine	C46H56N4O10	5978	Moderate		Inter Info	[221], [125], [222]
D1699		Vincristine (liposome)	C46H56N4O10	5978	Moderate		Inter Info	[221], [125], [222]
D1714		Zafirlukast	C31H33N3O6S	5717	Moderate		Inter Info	[221], [125], [222]
D1715		Zalcitabine	C9H13N3O3	24066	Moderate		Inter Info	[218], [379]
D1237		Peginterferon alfa-2a	NA	NA	Moderate		Inter Info	[221], [125], [222]
D1238		Peginterferon alfa-2b	NA	NA	Moderate		Inter Info	[221], [125], [222]
D1329		Pravastatin	C23H36O7	54687	Moderate		Inter Info	[221], [125], [222]
D1551		Teniposide	C32H32O13S	452548	Moderate		Inter Info	[221], [125], [222]
D1700		Vinorelbine	C45H54N4O8	5311497	Moderate		Inter Info	[221], [125], [222]
	Increased risk of prolong QT interval					Drug Num: 164
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[7], [8], [9], [10]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[7], [8], [9], [11], [12], [13], [14]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[7], [8], [9], [18], [19], [20], [21], [22], [23], [24], [25], [26], [13]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[7], [8], [9], [27]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[7], [8], [9], [28], [29], [13]
D0740		Grepafloxacin	C19H22FN3O3	72474	Major		Inter Info	[30], [7], [8], [9], [31], [32], [33]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[7], [8], [9], [34], [35], [36], [37], [38], [39], [13]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[7], [8], [9], [40]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[7], [8], [9], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [13]
D1092		Moxifloxacin	C21H24FN3O4	152946	Major		Inter Info	[51], [30], [52], [7], [8], [9], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72]
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[7], [8], [9], [18], [19], [20], [21], [22], [23], [24], [25], [26], [13]
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[74]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[79]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[7], [8], [9], [18], [19], [20], [21], [22], [23], [24], [25], [26], [13]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[9], [80]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[7], [8], [9], [81]
D0320		Chloroquine	C18H26ClN3	2719	Major		Inter Info	[82], [9], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[101]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[7], [8], [9], [104]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[7], [8], [9], [105]
D0554		Efavirenz	C14H9ClF3NO2	64139	Major		Inter Info	[106]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[7], [107], [8], [9], [108], [109], [13]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[51], [30], [52], [7], [8], [9], [53], [54], [55], [56], [57], [58], [59], [60], [61], [62], [63], [64], [65], [66], [67], [68], [69], [70], [71], [72]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[111], [7], [8], [9], [112], [113], [114], [115], [116]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Major		Inter Info	[82], [9], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[7], [8], [9], [117], [13]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[120]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[121]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[9], [123], [13]
D0960		Lumefantrine	C30H32Cl3NO	6437380	Major		Inter Info	[8], [9], [125]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[126]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[7], [8], [9], [127], [13]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[7], [8], [9], [128]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[7], [8], [9], [17]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[130]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[132]
D1223		Papaverine	C20H21NO4	4680	Major		Inter Info	[133], [134], [135], [136], [137], [138], [139], [140]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[7], [8], [9], [141]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[9], [28], [143], [13]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[7], [8], [9], [18], [19], [20], [21], [22], [23], [24], [25], [26], [13]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[7], [8], [9], [18], [19], [20], [21], [22], [23], [24], [25], [26], [13]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[7], [8], [9], [28], [57], [144], [145], [13]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[147], [148], [7], [8], [9], [149], [150]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[9], [151]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[30], [7], [8], [9], [155], [156], [55], [57], [59], [157], [60], [61], [158], [63], [64], [65], [66], [159], [70], [33], [160]
D1574		Thioridazine	C21H26N2S2	5452	Major		Inter Info	[7], [8], [9], [178], [28], [179], [180], [181], [13]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[7], [8], [9], [186]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Major		Inter Info	[7], [8], [9], [188]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[7], [8], [9], [189]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[7], [8], [9], [18], [19], [20], [21], [22], [23], [24], [25], [26], [13]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[7], [8], [9], [28], [190], [13]
D0003		Abarelix	C72H95ClN14O14	16131215	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D0036		Alfuzosin	C19H27N5O4	2092	Moderate		Inter Info	[7], [8], [9], [202], [13]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0139		Azithromycin	C38H72N2O12	447043	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0597		Erythromycin	C37H67NO13	12560	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0682		Flutamide	C11H11F3N2O3	3397	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D0737		Goserelin	C59H84N18O14	5311128	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0908		Leuprolide	C59H84N16O12	657181	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[263]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[8], [9], [264]
D0007		Abiraterone	C24H31NO	132971	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[57], [145], [13]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[7], [8], [9], [274], [13]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[8], [9], [275], [276], [277], [278], [279], [280]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[7], [8], [9], [281], [13]
D0115		Astemizole	C28H31FN4O	2247	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0180		Bicalutamide	C18H14F4N2O4S	2375	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[9], [288]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0349		Clarithromycin	C38H69NO13	84029	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[296]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[297]
D0437		Degarelix	C82H103ClN18O16	16136245	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[57], [145], [13]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[8], [9], [304]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[7], [8], [9], [305]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[8], [9], [306]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0700		Fostemsavir	C25H26N7O8P	11319217	Moderate		Inter Info	[308]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[30], [59], [60], [65], [311]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[312]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[313]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0758		Histrelin	C66H86N18O12	25077993	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0806		Inotuzumab ozogamicin	NA	NA	Moderate		Inter Info	[9], [315]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[30], [7], [8], [9], [55], [56], [57], [316], [317], [60], [61], [318], [62], [319], [63], [64], [65], [66], [320], [321], [322], [70], [33]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[9]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D0948		Lopinavir	C37H48N4O5	92727	Moderate		Inter Info	[7], [8], [324]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1137		Nilutamide	C12H10F3N3O4	4493	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D1155		Norfloxacin	C16H18FN3O3	4539	Moderate		Inter Info	[30], [7], [8], [9], [55], [56], [57], [316], [317], [60], [61], [318], [62], [319], [63], [64], [65], [66], [320], [321], [322], [70], [33]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[30], [7], [8], [9], [55], [56], [57], [316], [317], [60], [61], [318], [62], [319], [63], [64], [65], [66], [320], [321], [322], [70], [33]
D1169		Oliceridine	C22H30N2O2S	66553195	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[9], [330]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1254		Perflutren	C3F8	6432	Moderate		Inter Info	[331], [332]
D1257		Perphenazine	C21H26ClN3OS	4748	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[342]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1342		Probucol	C31H48O2S2	4912	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[343], [344], [345], [346], [347], [348], [349], [350], [351], [352]
D1368		Quetiapine	C21H25N3O2S	5002	Moderate		Inter Info	[7], [8], [9], [28], [353], [354], [355], [356], [13]
D1388		Relugolix	C29H27F2N7O5S	10348973	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1463		Sevoflurane	C4H3F7O	5206	Moderate		Inter Info	[7], [8], [9], [362]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[7], [8], [9], [365]
D1533		Tamoxifen	C26H29NO	2733526	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[7], [8], [9], [366], [367], [368]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[7], [8], [9], [369], [13]
D1596		Tizanidine	C9H8ClN5S	5487	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[371], [372], [275], [373], [374], [375], [13]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1651		Triptorelin	C64H82N18O13	25074470	Moderate		Inter Info	[9], [191], [192], [193], [194], [195], [196], [197]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[383], [384]
D1497		Sorafenib	C21H16ClF3N4O3	216239	Moderate		Inter Info	[7], [8], [9], [385]
D1555		Terfenadine	C32H41NO2	5405	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[7], [8], [9], [28], [57], [145], [13]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[7], [8], [9], [389], [390], [391], [392]
	Increased risk of ventricular arrhythmias					Drug Num: 37
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[110], [14]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[9], [118], [119]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[9], [131]
D1474		Siponimod	C29H35F3N2O3	44599207	Major		Inter Info	[8], [152]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260]
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[7], [265], [8], [9], [266], [267], [268], [269], [270], [271]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[7], [8], [9], [285], [286], [287]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[7], [8], [9], [285], [286], [287]
D0516		Donepezil	C24H29NO3	3152	Moderate		Inter Info	[7], [8], [9], [301], [302], [303]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[8], [9], [287]
D0707		Galantamine	C17H21NO3	9651	Moderate		Inter Info	[7], [8], [9], [301], [302], [303]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[7], [8], [9], [285], [286], [287]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[244], [254], [257]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[7], [8], [9], [285], [286], [287]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[7], [8], [9], [285], [286], [287]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[244], [254], [257]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[7], [8], [9], [285], [286], [287]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[7], [8], [9], [285], [286], [287]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[7], [8], [9], [285], [286], [287]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260]
D1185		Orciprenaline	C11H17NO3	4086	Moderate		Inter Info	[244], [254], [257]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[7], [8], [9], [285], [286], [287]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[9], [340], [341]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[9], [340], [341]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[8], [9], [287]
D1414		Ritodrine	C17H21NO3	33572	Moderate		Inter Info	[231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260]
D1418		Rivastigmine	C14H22N2O2	77991	Moderate		Inter Info	[7], [8], [9], [301], [302], [303]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[244], [254], [257]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[9], [340], [341]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[231], [232], [233], [234], [235], [236], [237], [238], [239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [252], [253], [254], [255], [256], [257], [258], [259], [260]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[244], [254], [257]
D1525		Tacrine	C13H14N2	1935	Moderate		Inter Info	[7], [8], [9], [301], [302], [303]
Pharmacodynamic antagonistic effects
	Antagonize the effect of vaccine/toxoid					Drug Num: 23
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1744		Bacillus calmette-guerin substrain tice live antigen	NA	NA	Major		Inter Info	[75], [76], [77]
D1839		Measles virus vaccine live attenuated	NA	NA	Major		Inter Info	[75], [76], [77]
D1849		Mumps virus strain B level jeryl lynn live antigen	NA	NA	Major		Inter Info	[75], [76], [77]
D1881		Rotavirus vaccine	NA	NA	Major		Inter Info	[75], [76], [77]
D1882		Rubella virus vaccine	NA	NA	Major		Inter Info	[75], [76], [77]
D1890		Smallpox (Vaccinia) Vaccine, Live	NA	NA	Major		Inter Info	[153], [8], [154]
D1897		Talimogene laherparepvec	NA	NA	Major		Inter Info	[161]
D1914		Typhoid vaccine (live)	NA	NA	Major		Inter Info	[75], [76], [77]
D1920		Varicella Zoster Vaccine (Recombinant)	NA	NA	Major		Inter Info	[75], [76], [77]
D1922		Yellow Fever Vaccine	NA	NA	Major		Inter Info	[75], [76], [77]
D1838		Lyme disease vaccine (recombinant OspA)	NA	NA	Moderate		Inter Info	[261]
D0089		Anthrax vaccine	NA	NA	Moderate		Inter Info	[153], [272], [273]
D0366		Clostridium tetani toxoid antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[153], [272], [273]
D0755		Hepatitis A Vaccine	NA	NA	Moderate		Inter Info	[153], [272], [273]
D0756		Hepatitis B Vaccine (Recombinant)	NA	NA	Moderate		Inter Info	[153], [272], [273]
D0767		Human papillomavirus type 11 L1 capsid protein antigen	NA	NA	Moderate		Inter Info	[153], [272], [273]
D0803		Influenza A virus A/California/7/2009 (H1N1)-like antigen (propiolactone inactivated)	NA	NA	Moderate		Inter Info	[153], [272], [273]
D0804		Influenza A virus A/Vietnam/1194/2004 (H5N1) antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[153], [272], [273]
D0999		Meningococcal polysaccharide vaccine group C	NA	NA	Moderate		Inter Info	[153], [272], [273]
D1259		Pfizer-BioNTech Covid-19 Vaccine	NA	NA	Moderate		Inter Info	[333], [153], [8], [334], [335], [336], [272], [337], [338], [339], [273]
D1307		Poliovirus type 1 antigen (formaldehyde inactivated)	NA	NA	Moderate		Inter Info	[153], [272], [273]
D1662		Typhoid vaccine (inactivated)	NA	NA	Moderate		Inter Info	[153], [272], [273]
D1692		Vibrio cholerae CVD 103-HgR strain live antigen	NA	NA	Moderate		Inter Info	[153], [272], [273]
	Antagonize the effect of probiotics					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1749		Bifidobacterium longum infantis	NA	NA	Moderate		Inter Info	[282], [283], [284]
D1827		Lactobacillus acidophilus	NA	NA	Moderate		Inter Info	[282], [283], [284]
	Diminish the response to diagnostic skin test antigens					Drug Num: 4
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1755		Candida albicans	C29H27N2O12P	118855431	Moderate		Inter Info	[291], [292], [293]
D1765		Coccidioides immitis spherule	NA	NA	Moderate		Inter Info	[291], [292], [293]
D1912		Trichophyton mentagrophytes	NA	NA	Moderate		Inter Info	[291], [292], [293]
D1913		Tuberculin purified protein derivative	NA	NA	Moderate		Inter Info	[291], [292], [293]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 3
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0659		Filgrastim	NA	NA	Moderate		Inter Info	[224], [225], [226]
D1235		Pegfilgrastim	C27H46N4O19	70683024	Moderate		Inter Info	[381], [382]
D1446		Sargramostim	NA	NA	Moderate		Inter Info	[224], [225], [226]

References
1	Product Information. Cimzia (certolizumab). UCB Pharma Inc, Smyrna, GA.
2	Product Information. Enbrel (etanercept). Wyeth-Ayerst Laboratories, Philadelphia, PA.
3	Product Information. Humira (adalimumab). Abbott Pharmaceutical, Abbott Park, IL.
4	Product Information. Remicade (infliximab). Centocor Inc, Malvern, PA.
5	Product Information. Simponi (golimumab). Centocor Inc, Malvern, PA.
6	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Drug labels for the Tumor Necrosis Factor-alpha (TNFa) blockers now include warnings about infection with Legionella and Listeria bacteria. ".
7	Canadian Pharmacists Association.
8	Cerner Multum, Inc. "Australian Product Information.".
9	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
10	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
11	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
12	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
13	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
14	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
15	Product Information. Leustatin (cladribine). Ortho Biotech Inc, Raritan, NJ.
16	Product Information. Clozaril (clozapine). Novartis Pharmaceuticals, East Hanover, NJ.
17	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
18	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
19	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
20	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
21	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
22	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
23	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
24	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
25	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
26	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
27	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
28	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
29	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
30	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
31	Lode H, Vogel F, Elies W "Grepafloxacin: A review of its safety profile based on clinical trials and postmarketing surveillance." Clin Ther 21 (1999): 61-74. [PMID: 10090425]
32	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
33	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
34	Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y "The association between intravenous haloperidol and prolonged QT interval." J Clin Psychopharmacol 21 (2001): 257-61. [PMID: 11386487]
35	Huyse F, van Schijndel RS "Haloperidol and cardiac arrest." Lancet 2 (1988): 568-9. [PMID: 2900948]
36	Metzger E, Friedman R "Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill." J Clin Psychopharmacol 13 (1993): 128-32. [PMID: 8463445]
37	O'Brien JM, Rockwood RP, Suh KI "Haloperidol-induced torsade de pointes." Ann Pharmacother 33 (1999): 1046-9. [PMID: 10534216]
38	Product Information. Haldol (haloperidol). McNeil Pharmaceutical, Raritan, NJ.
39	Wilt JL, Minnema AM, Johnson RF, Rosenblum AM "Torsade de pointes associated with the use of intravenous haloperidol." Ann Intern Med 119 (1993): 391-4. [PMID: 8338292]
40	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
41	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
42	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
43	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
44	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
45	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
46	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
47	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
48	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
49	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
50	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
51	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
52	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
53	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
54	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
55	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
56	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
57	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
58	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
59	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
60	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
61	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
62	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
63	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
64	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
65	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
66	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
67	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
68	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
69	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
70	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
71	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
72	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
73	Product Information. Tysabri (natalizumab). Elan Pharmaceutical/Athena Neurosciences Inc, South San Francisco, CA.
74	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
75	Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL, eds. "Harrison's Principles of Internal Medicine. 14th ed." New York, NY: McGraw-Hill Health Professionals Division (1998).
76	Product Information. Attenuvax (measles virus vaccine, live, attenuated). Merck &amp Co, Inc, West Point, PA.
77	Product Information. YF-Vax (yellow fever vaccine). sanofi pasteur, Swiftwater, PA.
78	Product Information. Olumiant (baricitinib). Lilly, Eli and Company, Indianapolis, IN.
79	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
80	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
81	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
82	Harper KM, Knapp DJ, Criswell HE, Breese GR "Vasopressin and alcohol: A multifaceted relationship." Psychopharmacology (Berl) 235 (2018): 3363-79. [PMID: 32936259]
83	Javelot H, El-Hage W, Meyer G, Becker G, Michel B, Hingray C "COVID-19 and (hydroxy)chloroquine-azithromycin combination: should we take the risk for our patients?" Br J Clin Pharmacol Apr 29 (2020): epub ahead of print. [PMID: 32350872]
84	National Institutes of Health (NIH) "Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.".
85	Product Information. Chloroquine Phosphate (chloroquine). West-Ward Pharmaceutical Corporation, Eatontown, NJ.
86	Product Information. Hydroxychloroquine Sulfate (hydroxychloroquine). Prasco Laboratories, Cincinnati, OH.
87	Product Information. Plaquenil (R). (hydroxychloroquine). Sanofi Winthrop Pharmaceuticals, New York, NY.
88	Roden DM, Harrington RA, Poppas A, Russo AM "Considerations for drug interactions on QTc in exploratory COVID-19 (Coroanvirus disease 2019) treatment." Heart Rhythm Apr 14 (2020): epub ahead of print. [PMID: 32302703]
89	Sacher F, Fauchier L, Boveda S, et.al "Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection." Arch Cardiovasc Dis Apr 24 (2020): epub ahead of print. [PMID: 32354666]
90	Saleh M, Gabriels J, ChangD, et.al "The effect of chloroquine, hydroxychloroquine and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection." Circ Arrhythm Electrophysiol Apr 29 (2020): epub ahead of print. [PMID: 32347743]
91	Sapp JL, Alqarawi W, MacIntyre CJ, et.al "Guidance on minimizing risk of drug-induced ventricular arrhythmia during treatment of COVID-19: A statement from the Canadian Heart Rhythm Society." Can J Cardiol Apr 8 (2020): epub ahead of print. [PMID: 32299753]
92	Smit C, Peeters MYM, van den Anker JN, Knibbe CAJ "Chloroquine for SARS-CoV-2: Implications of its unique pharmacokinetic and safety properties." Clin Pharmacokinet Ar 18 (2020): epub ahead of print. [PMID: 32306288]
93	Bessiere F, Roccia H, Deliniere A, et.al "Assessment of QT intervals in a case series of patients with coronavirus disease 2019 (COVID-19) infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit." JAMA Cardiol May 1 (2020): epub ahead of print. [PMID: 32936266]
94	Borba MGS, Val FFA, Sampaio VS, et.al "Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 1 (SARS-CoV-2) infection: A randomized clinical trial." JAMA Netw Open Apr 1 (2020): epub ahead of print. [PMID: 32330277]
95	Giudicessi JR, Noseworthy PA, Friedman PA, Ackerman MJ "Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)" Mayo Clin Proc Apr 7 (2020): epub ahead of print. [PMID: 32359771]
96	Kapoor A, Pandurangi U, Arora V, et.al "Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society." Indian Pacing Electorphysiol J Apr 8 (2020): epub ahead of print. [PMID: 32278018]
97	Mercuro NJ, Yen CF, Shim DJ, et.al "Risk of QT interval prolongation associated with the use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)" JAMA Cardiol May 1:e201834 (2020): epub ahead of print. [PMID: 32936252]
98	mitra RL, Greenstein SA, Epstein lm "An algorithm for managing QT prolongation in coronavirus disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin Possible benefits of intravenous lidocaine." HeartRythm Case Rep Apr 1 (2020): epub ahead of print. [PMID: 32363145]
99	US Food and Drug Administration "FACT SHEET FOR HEALTH CARE PROVIDERS EMERGENCY USE AUTHORIZATION (EUA) OF CHLOROQUINE PHOSPHATE SUPPLIED FROM THE STRATEGIC NATIONAL STOCKPILE FOR TREATMENT OF COVID-19 IN CERTAIN HOSPITALIZED PATIENTS. Available from: URL: https://www.fda.gov/media/13653" ([2020, Apr 27]):.
100	US Food and Drug Administration "Hydroxychloroquine or Chloroquine for COVID-19: Drug Safety Communication - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems.".
101	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
102	Product Information. Ferriprox (deferiprone). ApoPharma USA Inc, Rockville, MD.
103	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
104	Product Information. Anzemet (dolasetron). Hoechst Marion-Roussel Inc, Kansas City, MO.
105	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
106	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
107	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
108	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
109	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
110	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
111	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
112	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
113	Nosten F, ter Kuile FO, Luxemburger C, et al "Cardiac effects of antimalarial treatment with halofantrine." Lancet 341 (1993): 1054-6. [PMID: 8096959]
114	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
115	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
116	Sudden death in a traveler following halofantrine administration--Togo, 2000. MMWR Morb Mortal Wkly Rep 50 (2001): 169-70, 179. [PMID: 11393488]
117	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
118	Mittal SR "Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine." J Assoc Physicians India 62 (2014): 426-7. [PMID: 25438492]
119	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
120	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
121	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
122	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
123	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
124	Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
125	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
126	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
127	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
128	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
129	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
130	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
131	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
132	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
133	Goto M, Sato M, Kitzazawa H, et.al "Papaverine-induced QT interval prolongation and ventricular fibrillation in a patient with a history of drug-induced QT prolongation." Intern Med 53 (2014): 1629-31. [PMID: 25088875]
134	Inoue T, Asahi S, Takayanagi K, Morooka S, Takabatake Y "QT prolongation and possibility of ventricular arrhythmias after intracoronary papaverine." Cardiology 84 (1994): 9-13. [PMID: 7511988]
135	Jain A, Jenkins MG "Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine." Cathet Cardiovasc Diagn 18 (1989): 255-7. [PMID: 2605630]
136	Kern MJ, Deligonul U, Serota H, Gudipati C, Buckingham T "Ventricular arrhythmia due to intracoronary papaverine: analysis of QT intervals and coronary vasodilatory reserve." Cathet Cardiovasc Diagn 19 (1990): 229-36. [PMID: 2334953]
137	Nakayama M, Saito A, Kitazawa H, et.al "Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases." Intern Med 51 (2012): 351-6. [PMID: 22333368]
138	Nakayama M, Tanaka N, Sakoda K, et.al "Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease." Circ J 79 (2015): 530-6. [PMID: 25746536]
139	Talman CL, Winniford MD, Rossen JD, Simonetti I, Kienzle MG, Marcus ML "Polymorphous ventricular tachycardia: a side effect of intracoronary papaverine." J Am Coll Cardiol 15 (1990): 275-8. [PMID: 2299067]
140	Vrolix M, Piessens J, De Geest H "Torsades de pointes after intracoronary papaverine." Eur Heart J 12 (1991): 273-6. [PMID: 2044564]
141	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
142	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
143	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
144	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
145	Witchel HJ, Hancox JC, Nutt DJ "Psychotropic drugs, cardiac arrhythmia, and sudden death." J Clin Psychopharmacol 23 (2003): 58-77. [PMID: 12544377]
146	Product Information. Quadramet (samarium sm 153 lexidronam) Berlex Laboratories, Richmond, CA.
147	Anson BD, Weaver JG, Ackerman MJ, et al. "Blockade of HERG channels by HIV protease inhibitors." Lancet 365 (2005): 682-686. [PMID: 15721475]
148	Biondi L "Health Canada endorsed important safety information on Invirase (saquinavir mesylate)." .
149	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
150	FDA. U.S. Food and Drug Administration "FDA drug safety communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms.".
151	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
152	Product Information. Mayzent (siponimod). Novartis Pharmaceuticals, East Hanover, NJ.
153	CDC. Centers for Disease Control and Prevention/ "Recommendations of the advisory committtee on immunization practices (ACIP): use of vaccines and immune globulins in persons with altered immunocompetence." MMWR Morb Mortal Wkly Rep 42(RR-04) (1993): 1-18. [PMID: 20300058]
154	Product Information. Dryvax (smallpox vaccine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
155	Demolis JL, Charransol A, Funck-Brentano C, Jaillon P "Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers." Br J Clin Pharmacol 41 (1996): 499-503. [PMID: 8799513]
156	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
157	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
158	Lipsky BA, Dorr MB, Magner DJ, Talbot GH "Safety profile of sparfloxacin, a new fluoroquinolone antibiotic." Clin Ther 21 (1999): 148-59. [PMID: 10090432]
159	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
160	Zix JA, GeerdesFenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
161	Product Information. Imlygic (talimogene laherparepvec). Amgen USA, Thousand Oaks, CA.
162	Bennett CL, Nebeker JR, Samore MH, et al "The Research on Adverse Drug Events and Reports (RADAR) project." JAMA 293 (2005): 2131-40. [PMID: 15870417]
163	Bennett CL, Schumock GT, Desai AA, et al "Thalidomide-associated deep vein thrombosis and pulmonary embolism." Am J Med 113 (2002): 603-6. [PMID: 12459408]
164	Cavo M, Zamagni E, Cellini C, et al. "Deep-vein thrombosis in patients with multiple myeloma receiving first-line thalidomide-dexamethasone therapy." Blood 100 (2002): 2272-3. [PMID: 12229885]
165	Escudier B, Lassau N, Leborgne S, Angevin E, Laplanche A "Thalidomide and venous thrombosis." Ann Intern Med 136 (2002): 711. [PMID: 11992318]
166	Figg WD, Arlen P, Gulley J, et al. "A randomized phase II trial of docetaxel (taxotere) plus thalidomide in androgen-independent prostate cancer." Semin Oncol 28(4 Suppl 15) (2001): 62-6. [PMID: 11685731]
167	Fine HA, Wen PY, Maher EA, et al. "Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas." J Clin Oncol 21 (2003): 2299-304. [PMID: 12805330]
168	Lee CK, Barlogie B, Munshi N, et al "DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma." J Clin Oncol 21 (2003): 2732-9. [PMID: 12860952]
169	Osman K, Comenzo R, Rajkumar SV "Deep venous thrombosis and thalidomide therapy for multiple myeloma." N Engl J Med 344 (2001): 1951-2. [PMID: 11419443]
170	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
171	Rajkumar SV, Hayman S, Gertz MA, et al. "Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma." J Clin Oncol 20 (2002): 4319-23. [PMID: 12409330]
172	Urbauer E, Kaufmann H, Nosslinger T, Raderer M, Drach J "Thromboembolic events during treatment with thalidomide." Blood 99 (2002): 4247-8. [PMID: 12043695]
173	Weber D, Rankin K, Gavino M, Delasalle K, Alexanian R "Thalidomide alone or with dexamethasone for previously untreated multiple myeloma." J Clin Oncol 21 (2003): 16-9. [PMID: 12506164]
174	Zangari M, Anaissie E, Barlogie B, et al "Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy." Blood 98 (2001): 1614-5. [PMID: 11520815]
175	Zangari M, Barlogie B, Anaissie E, et al "Deep vein thrombosis in patients with mutiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation." Br J Haematol 126 (2004): 715-21. [PMID: 15327525]
176	Zangari M, Siegel E, Barlogie B, et al "Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy." Blood 100 (2002): 1168-71. [PMID: 12149193]
177	Desai AA, Vogelzang NJ, Rini BI, Ansari R, Krauss S, Stadler WM "A high rate of venous thromboembolism in a multi-institutional Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma." Cancer 95 (2002): 1629-36. [PMID: 12365009]
178	Fletcher GF, Kazamias TM "Cardiotoxic effects of Mellaril: conduction disturbances and supraventricular arrhythmias." Am Heart J 78 (1969): 135-8. [PMID: 5794785]
179	Hartigan-Go K, Bateman DN, Nyberg G, Martensson E, Thomas SHL "Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans." Clin Pharmacol Ther 60 (1996): 543-53. [PMID: 8941027]
180	Liberatore MA, Robinson DS "Torsade de pointes: a mechanism for sudden death associated with neuroleptic drug therapy?" J Clin Psychopharmacol 4 (1984): 143-6. [PMID: 6145728]
181	Product Information. Mellaril (thioridazine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
182	Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
183	Chou TC, Motzer RJ, Tong Y, Bosl GJ "Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design." J Natl Cancer Inst 86 (1994): 1517-24.[PMID: 7932806]
184	Product Information. Hycamtin (topotecan). SmithKline Beecham, Philadelphia, PA.
185	Rowinsky EK, Kaufmann SH, Baker SD, et al. "Sequences of topotecan and cisplatin: phase I, pharmacologic, and in vitro studies to examine sequence dependence."?J Clin Oncol. 1996;14(12):3074-3084.[PMID: 8955652]
186	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
187	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
188	Product Information. Vandetanib (vandetanib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
189	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
190	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
191	Product Information. Eligard (leuprolide). Sanofi Winthrop Pharmaceuticals, New York, NY.
192	Product Information. Firmagon (degarelix). Ferring Pharmaceuticals Inc, Tarrytown, NY.
193	Product Information. Lupron (leuprolide). TAP Pharmaceuticals Inc, Deerfield, IL.
194	Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc, Waltham, MA.
195	Product Information. Trelstar (triptorelin) Pharmacia and Upjohn, Kalamazoo, MI.
196	Product Information. Vantas (histrelin). Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.
197	Product Information. Zoladex (goserelin). Zeneca Pharmaceuticals, Wilmington, DE.
198	Product Information. Fluorouracil injection (fluorouracil). Roche Laboratories, Nutley, NJ.
199	Product Information. Amevive (alefacept). Biogen, Cambridge, MA.
200	Product Information. Lonsurf (tipiracil-trifluridine). Taiho Oncology, Inc., Princeton, NJ.
201	Product Information. Campath (alemtuzumab) Berlex, Richmond, CA.
202	Product Information. Uroxatral (alfuzosin). sanofi-aventis , Bridgewater, NJ.
203	Product Information. Eloxatin (oxaliplatin). Sanofi Winthrop Pharmaceuticals, New York, NY.
204	Product Information. Arcalyst (rilonacept). Regeneron Pharmaceuticals Inc, Tarrytown, NY.
205	Product Information. Ilaris (canakinumab). Novartis Pharmaceuticals, East Hanover, NJ.
206	Product Information. Kineret (anakinra). Amgen, Thousand Oaks, CA.
207	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
208	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
209	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
210	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
211	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
212	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
213	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
214	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
215	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
216	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
217	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
218	Argov Z, Mastaglia FL "Drug-induced peripheral neuropathies." Br Med J 1 (1979): 663-6. [PMID: 219931]
219	Cavaletti G, Jakubowiak AJ "Peripheral neuropathy during bortezomib treatment of multiple myeloma: a review of recent studies." Leuk Lymphoma 51 (2010): 1178-87. [PMID: 20497001]
220	Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
221	Carrion C, Espinosa E, Herrero A, Garcia B "Possible vincristine-isoniazid interaction." Ann Pharmacother 29 (1995): 201. [PMID: 7756727]
222	Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online."
223	Product Information. Raptiva (efalizumab). Genentech, South San Francisco, CA.
224	Product Information. Granix (tbo-filgrastim). Teva Pharmaceuticals USA, North Wales, PA.
225	Product Information. Leukine (sargramostim). Immunex Corporation, Seattle, WA.
226	Product Information. Stemgen (ancestim) Amgen, Thousand Oaks, CA.
227	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
228	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
229	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
230	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
231	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
232	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
233	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
234	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
235	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
236	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
237	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
238	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
239	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
240	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
241	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
242	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
243	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
244	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
245	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
246	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
247	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
248	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
249	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
250	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
251	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
252	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
253	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
254	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
255	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
256	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
257	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
258	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
259	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
260	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
261	Shen AK, Mead PS, Beard CB. The Lyme disease vaccine--a public health perspective. Clin Infect Dis. 2011;52 Suppl 3:s247-s252. [PMID: 21217171]
262	Canadian Pharmacists Association "e-CPS."
263	Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
264	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
265	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
266	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
267	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
268	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
269	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
270	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
271	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
272	Product Information. Imovax Rabies (rabies vaccine). sanofi pasteur, Swiftwater, PA.
273	Department of Health. National Health Service "Immunisation Against Infectious Disease - "The Green Book". Chapter 6: Contraindications and special considerations.".
274	Product Information. Apokyn (apomorphine). Mylan Pharmaceuticals Inc, Morgantown, WV.
275	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
276	Kane JM, Carson WH, Saha AR, et al. "Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder." J Clin Psychiatry 63 (2002): 763-71. [PMID: 12363115]
277	Keck PE Jr, Marcus R, Tourkodimitris S, et al. "A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania." Am J Psychiatry 160 (2003): 1651-8. [PMID: 12944341]
278	Nelson S, Leung JG "Torsades de Pointes After Administration of Low-Dose Aripiprazole (February)." Ann Pharmacother (2013):. [PMID: 23362038]
279	Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study." J Clin Psychiatry 64 (2003): 1048-56. [PMID: 14628980]
280	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
281	Product Information. Saphris (asenapine). Schering-Plough Corporation, Kenilworth, NJ.
282	Borriello SP, Hammes WP, Holzapfel W, et.al "Safety of probiotics that contain lactobacilli or bifidobacteria." Clin Infect Dis 36 (2003): 775-80. [PMID: 12627362]
283	Schlegel L, Lemerle S, Geslin P "Lactobacillus species as opportunistic pathogens in immunocompromised patients." Eur J Clin Microbiol Infect Dis 17 (1998): 887-8. [PMID: 10052559]
284	Salminen MK, Tynkkynen S, Rautelin H, et al. "Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland." Clin Infect Dis 35 (2002): 1155-60. [PMID: 12410474]
285	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
286	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
287	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
288	Abbas R, Hug BA, Leister C, Sonnichsen D "A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects." Int J Cancer 131 (2012): Epub. [PMID: 22065400]
289	Product Information. Accolate (zafirlukast). Zeneca Pharmaceuticals, Wilmington, DE.
290	Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
291	Product Information. Tuberculin PPD (Mantoux) (tuberculin purified protein derivative). Connaught Laboratories Ltd, Toronto, ON.
292	Product Information. Candin (candida albicans extract). Nielsen Biosciences Inc, San Diego, CA.
293	Product Information. Spherulin (coccidioidin skin test). ALK Laboratories Inc, Wallingford, CT.
294	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
295	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
296	Product Information. Lamprene (clofazimine). Novartis Pharmaceuticals, East Hanover, NJ.
297	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
298	Product Information. Prolia (denosumab). Amgen USA, Thousand Oaks, CA.
299	Product Information. Austedo (deutetrabenazine). Teva Pharmaceuticals USA, North Wales, PA.
300	Product Information. Vumerity (diroximel fumarate). Alkermes, Inc, Cambridge, MA.
301	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
302	Product Information. Exelon (rivastigmine) Novartis Pharmaceuticals, East Hanover, NJ.
303	Product Information. Razadyne (galantamine). Johnson and Johnson Medical Inc, Arlington, TX.
304	Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
305	Product Information. Halaven (eribulin). Eisai Inc, Teaneck, NJ.
306	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
307	Product Information. Ancobon (flucytosine). Roche Laboratories, Nutley, NJ.
308	Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
309	Product Information. Cytovene (ganciclovir). Genentech, South San Francisco, CA.
310	Product Information. Valcyte (valganciclovir) Roche Laboratories, Nutley, NJ.
311	Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
312	Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
313	Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
314	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
315	Product Information. Besponsa (inotuzumab ozogamicin). Wyeth Laboratories, Philadelphia, PA.
316	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs. Prolongation of QT interval is probably a class effect of fluoroquinolones." Br Med J 322 (2001): 46-7. [PMID: 11141163]
317	Kahn JB "Latest industry information on the safety profile of levofloxacin in the US." Chemotherapy 47 Suppl 3 (2001): 32-7. [PMID: 11549787]
318	Makaryus AN, Byrns K, Makaryus MN, Natarajan U, Singer C, Goldner B "Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event?" South Med J 99 (2006): 52-6. [PMID: 16466123]
319	Nykamp DL, Blackmon CL, Schmidt PE, Roberson AG "QTc prolongation associated with combination therapy of levofloxacin, imipramine, and fluoxetine." Ann Pharmacother 39 (2005): 543-6. [PMID: 15687478]
320	Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
321	Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
322	Samaha FF "QTC interval prolongation and polymorphic ventricular tachycardia in association with levofloxacin." Am J Med 107 (1999): 528-9. [PMID: 10569314]
323	Product Information. Lucemyra (lofexidine). US WorldMeds LLC, Louisville , KY.
324	Product Information. Kaletra (lopinavir-ritonavir) Abbott Pharmaceutical, Abbott Park, IL.
325	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
326	Product Information. Zejula (niraparib). Tesaro Inc., Waltham, MA.
327	Product Information. Ocrevus (ocrelizumab). Genentech, South San Francisco, CA.
328	Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
329	Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
330	Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
331	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
332	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
333	CDC Centers for Disease Control and Prevention "General Best Practice Guidelines for Immunization: Altered Immunocompetence." .
334	Product Information. Biothrax (anthrax vaccine adsorbed). Emergent BioSolutions Inc., Lansing, MI.
335	Product Information. Fluzone Influenza Vaccine (influenza virus vaccine). Connaught, Swiftwater, PA.
336	Product Information. Havrix (hepatitis A vaccine). SmithKline Beecham, Philadelphia, PA.
337	Product Information. Influenza Virus Vaccine, H5N1, Inactivated (influenza virus vaccine, H5N1, inactivated). GlaxoSmithKline, Research Triangle Park, NC.
338	Product Information. Omnihib (haemophilus b conjugate vaccine). SmithKline Beecham, Philadelphia, PA.
339	CDC Centers for Disease Control and Prevention "Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States.".
340	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
341	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
342	Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
343	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
344	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
345	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
346	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
347	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
348	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
349	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
350	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
351	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
352	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
353	Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
354	Sala M, Vicentini A, Brambilla P, et al. "QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy." Ann Gen Psychiatry 4 (2005): 1. [PMID: 15845138]
355	Vieweg WV "New generation antipsychotic drugs and QTc interval prolongation." Prim Care Companion J Clin Psychiatry 5 (2003): 205-15. [PMID: 15213787]
356	Vieweg WV, Schneider RK, Wood MA "Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine." Acta Psychiatr Scand 112 (2005): 318-22. [PMID: 16156840]
357	Product Information. Xofigo (radium Ra 223 dichloride). Bayer Pharmaceutical Inc, West Haven, CT.
358	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
359	Gilead Sciences, Inc "About Remdesivir.".
360	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
361	Product Information. Daxas (roflumilast). Nycomed Inc, Princeton, NJ.
362	Product Information. Ultane (sevoflurane). Abbott Pharmaceutical, Abbott Park, IL.
363	AnazaoHealth Corporation "P32 Sodium Phosphate."
364	Multum Information Services, Inc. Expert Review Panel.
365	Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
366	Demolis JL, Vacheron F, Cardus S, Funck-Brentano C "Effect of single and repeated oral doses of telithromycin on cardiac QT interval in healthy subjects." Clin Pharmacol Ther 73 (2003): 242-52. [PMID: 12621389]
367	Product Information. Ketek (telithromycin). Aventis Pharmaceuticals, Bridgewater, NJ.
368	European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products "European Public Assessment Report Ketek (telithromycin) (Rev. 2) ".
369	Product Information. Xenazine (tetrabenazine). Prestwick Pharmaceuticals Inc, Washington DC, VA.
370	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
371	Antonelli D, Atar S, Freedberg NA, Rosenfeld T "Torsade de pointes in patients on chronic amiodarone treatment: contributing factors and drug interactions." Isr Med Assoc J 7 (2005): 163-5. [PMID: 15792261]
372	Dattilo PB, Nordin C "Prolonged QT associated with an overdose of trazodone." J Clin Psychiatry 68 (2007): 1309-10. [PMID: 17854263]
373	Levenson JL "Prolonged QT interval after trazodone overdose." Am J Psychiatry 156 (1999): 969-70. [PMID: 10360146]
374	Mazur A, Strasberg B, Kusniec J, Sclarovsky S "QT prolongation and polymorphous ventricular tachycardia associated with trasodone-amiodarone combination." Int J Cardiol 52 (1995): 27-9. [PMID: 8707432]
375	Product Information. Oleptro (traZODone). Labopharm Inc, Laval, AL.
376	Product Information. Stelara (ustekinumab). Centocor Inc, Malvern, PA.
377	Product Information. Valtrex (valacyclovir). Glaxo Wellcome, Research Triangle Park, NC.
378	Product Information. Ingrezza (valbenazine). Neurocrine Biosciences, Inc., San Diego, CA.
379	Product Information. Hivid (zalcitabine). Roche Laboratories, Nutley, NJ.
380	Product Information. Kepivance (palifermin). Shire US Inc, Florence, KY.
381	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
382	Product Information. Neulasta (pegfilgrastim). Amgen, Thousand Oaks, CA.
383	European Medicines Agency "CHMP Assessment Report for Latixa. International nonproprietary name: ranolazine.".
384	Product Information. Ranexa (ranolazine). Calmoseptine Inc, Huntington Beach, CA.
385	Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
386	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
387	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
388	Product Information. Retrovir (zidovudine). Glaxo Wellcome, Research Triangle Park, NC.
389	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
390	Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
391	Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
392	Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence